supported in part by a grant from the National High Technology Research and Development Program of China(No.2012AA02A501)
Introduction:An increasing number of targeted drugs have been tested for the treatment of nasopharyngeal carcinoma(NPC).However,targeted therapy-related oncogenic mutations have not been fully evaluated.This study aim...